News
MicroPort NeuroTech™ NUMEN Receives Marketing Approval in Japan - 27 Aug 2022
MicroPort NeuroTech™ has received marketing approval issued by Ministr...MicroPort® MedBot™ Announces 2022 Interim Results - 26 Aug 2022
MicroPort® MedBot™ today announced the interim results of the Company ...Endovastec™ Announces 2022 Interim Results - 25 Aug 2022
Endovastec™ today announced the interim results of the Company and its...MicroPort NeuroTech™ APOLLO™ Completes First Implantation in Brazil - 19 Aug 2022
MicroPort NeuroTech™ recently announced that its independently develop...VitaFlow Liberty™ Obtains Marketing Approval in Colombia - 19 Aug 2022
CardioFlow Medtech recently announced VitaFlow Liberty™ has received m...MicroPort NeuroTech™ Completes First Implantation of NUMEN™ in Poland - 11 Aug 2022
MicroPort NeuroTech™ recently announced that its independently develop...MicroPort® MedBot™ JV’s R-ONE™ Completes Registration Clinical Trial - 01 Aug 2022
Shanghai Cathbot™ recently announced the completion of the clinical tr...MSC Announces First Clinical Use of TheFirst Rega™ Pacemaker in China - 28 Jul 2022
MSC recently announced the first batch of the Rega™ MRI-conditional im...Firehawk Pro™ Receives NMPA Approval for Marketing - 20 Jul 2022
MicroPort® has received approval from the Chinese NMPA to market its F...MicroPort NeuroTech™ Debuts on Main Board of HKEX - 15 Jul 2022
As the Pioneer & Largest Chinese Player in the Neuro-interventional Me...MicroPort® CRM Gets CE Mark Approval for INVICTA™ Defibrillation Leads - 13 Jul 2022
MicroPort® CRM has recently received CE Mark approval for its INVICTA™...Endovastec™ Presents Flagship Products at CICE 2022 - 10 Jul 2022
Endovastec™ eld a seminar at the International Congress of Endovascula...Endovastec™ Reewarm™ PTX DCB PTA Catheter Gets Approval in Brazil - 05 Jul 2022
Endovastec™ today announced that it has received registration approval...MicroPort® Participates in CIT 2022 and Hosts Joint Satellite Session - 01 Jul 2022
MicroPort® together with its subsidiaries recently participated in the...MicroPort® Releases 2-Year Results of Firesorb® Pivotal Trial FUTURE II - 30 Jun 2022
MicroPort® recently released the 2-year clinical follow-up results fro...MicroPort NeuroTech™ Completes Implantation of Numen™ in the U.S. - 28 Jun 2022
with Support from Rapid Medical as Exclusive Distributor...